sample_id	diagnosis	age	bmi	treatment	visit_date	bmi_flagged	_crucible_modified	_crucible_original	_crucible_reason
IBD001	CD	45	23.5	Infliximab	2024-01-15				
IBD002	CD	52	27.1	Adalimumab	2024-02-20		diagnosis=CD; visit_date=2024-02-20; treatment=Adalimumab	diagnosis=Crohn's; visit_date=2024/02/20; treatment=adalimumab	Normalized 'Crohn's' to 'CD'; Converted '2024/02/20' to ISO format '2024-02-20'; Normalized 'adalimumab' to 'Adalimumab'
IBD003	CD	38	21.8	Infliximab	2024-03-15		diagnosis=CD; visit_date=2024-03-15	diagnosis=cd; visit_date=15-Mar-2024	Normalized 'cd' to 'CD'; Converted '15-Mar-2024' to ISO format '2024-03-15'
IBD004	UC	41	24.2	Vedolizumab	2024-04-10				
IBD005	UC	29	-5.2	Mesalamine	2024-04-05	outlier	bmi_flagged=invalid_value; diagnosis=UC; visit_date=2024-04-05; treatment=Mesalamine; bmi_flagged=outlier	bmi_flagged=; diagnosis=ulcerative colitis; visit_date=April 5, 2024; treatment=mesalamine; bmi_flagged=	Flagged for review: issue in 'bmi'; Normalized 'ulcerative colitis' to 'UC'; Converted 'April 5, 2024' to ISO format '2024-04-05'; Normalized 'mesalamine' to 'Mesalamine'; Flagged for review: issue in 'bmi'
IBD006	CD	55	26.8	Ustekinumab	2024-05-22				
IBD007	CD	44	22.9	Infliximab	2024-06-18		treatment=Infliximab; diagnosis=CD	treatment=infliximab; diagnosis=Crohns	Normalized 'infliximab' to 'Infliximab'; Normalized 'Crohns' to 'CD'
IBD008	UC	33	28.5	Vedolizumab	2024-07-03				
